The introduction of a 750mcg parathyroid hormone injection in Australia has been somewhat restricted , with availability primarily via specialist clinicians and designated treatment centers. Initial sales figures for this higher dosage remain unavailable from the company, although reports suggest gradual adoption penetration. Distribution to indivi